CN Stock MarketDetailed Quotes

Yili Chuanning Biotechnology (301301)

Watchlist
  • 8.90
  • 0.000.00%
Market Closed May 29 15:00 CST
19.85BMarket Cap33.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Yili Chuanning Biotechnology (301301) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-15.61%1.09B
-19.83%4.62B
-22.90%3.44B
-26.50%2.35B
-14.85%1.3B
19.38%5.76B
24.43%4.46B
32.20%3.2B
19.96%1.52B
26.24%4.82B
Operating revenue
-15.61%1.09B
-19.83%4.62B
-22.90%3.44B
-26.50%2.35B
-14.85%1.3B
19.38%5.76B
24.43%4.46B
32.20%3.2B
19.96%1.52B
26.24%4.82B
Other operating revenue
----
7.73%389.55M
----
-7.26%167.18M
----
17.19%361.61M
----
10.06%180.27M
----
25.07%308.58M
Total operating cost
0.63%953.57M
-10.16%3.65B
-15.98%2.65B
-22.57%1.75B
-13.75%947.59M
11.26%4.06B
13.95%3.15B
18.97%2.26B
5.55%1.1B
12.55%3.65B
Operating cost
2.94%836.67M
-10.84%3.27B
-19.27%2.31B
-27.13%1.51B
-18.64%812.76M
10.99%3.66B
13.97%2.86B
19.43%2.07B
6.54%998.93M
14.87%3.3B
Operating tax surcharges
-20.60%17.15M
-15.68%67.21M
-17.57%55.64M
-14.64%39.64M
9.54%21.6M
19.59%79.7M
24.66%67.5M
24.55%46.43M
0.15%19.72M
21.31%66.65M
Operating expense
23.40%9.81M
14.29%29.19M
-2.18%19.14M
16.59%13.52M
106.68%7.95M
13.16%25.54M
33.78%19.57M
31.13%11.6M
-18.95%3.85M
96.96%22.57M
Administration expense
-5.51%54.36M
-8.06%152.02M
30.48%157.76M
33.51%110.13M
22.95%57.53M
15.52%165.34M
12.92%120.91M
12.33%82.49M
13.95%46.79M
-0.66%143.13M
Financial expense
76.10%13.49M
-37.02%30.46M
-40.17%25.4M
-42.84%15.84M
-39.50%7.66M
-20.51%48.36M
-3.82%42.46M
-4.63%27.71M
-47.17%12.67M
-50.55%60.83M
-Interest expense (Financial expense)
-17.49%8.93M
-45.37%33.82M
-12.62%30.82M
-16.24%21.41M
-29.85%10.82M
-29.47%61.91M
-45.02%35.27M
-46.24%25.56M
-44.06%15.43M
-38.33%87.78M
-Interest Income (Financial expense)
60.59%-674.2K
36.90%-4.66M
30.03%-3.9M
22.74%-3.01M
2.61%-1.71M
54.38%-7.38M
55.38%-5.58M
53.53%-3.89M
67.01%-1.76M
-210.78%-16.18M
Research and development
-44.91%22.09M
31.85%102.49M
89.80%83.64M
135.00%67.63M
140.34%40.09M
40.67%77.73M
12.82%44.07M
22.10%28.78M
21.11%16.68M
56.18%55.26M
Credit Impairment Loss
116.30%309.76K
-155.16%-3.69M
-448.19%-8.11M
-2,459.15%-6.1M
-353.17%-1.9M
202.82%6.69M
1,182.16%2.33M
326.69%258.72K
493.65%750.54K
54.41%-6.5M
Asset Impairment Loss
----
-40.85%-24.05M
-173.62%-23.13M
-173.62%-23.13M
----
59.97%-17.07M
73.25%-8.45M
73.25%-8.45M
----
-157.62%-42.65M
Other net revenue
-61.73%1.52M
-10.94%-11.97M
-147.89%-17.49M
-72.26%-20.13M
394.39%3.98M
79.68%-10.79M
80.52%-7.06M
69.91%-11.68M
91.36%-1.35M
-58.72%-53.11M
Fair value change income
---901.17K
-4,808.63%-1.48M
-135.13%-226.4K
101.94%4.35K
--0
102.66%31.5K
135.44%644.5K
95.84%-224.6K
76.75%-519.93K
-1,938.52%-1.18M
Invest income
-1,053.40%-1.86M
53.70%-4.26M
71.71%-2.03M
88.87%-702.78K
94.75%-160.91K
32.14%-9.2M
38.19%-7.16M
15.38%-6.31M
-325.42%-3.07M
-52.22%-13.55M
-Including: Investment income associates
-244.09%-2.27M
-618.09%-5.6M
-538.58%-2.33M
-1,275.88%-1.45M
-1,594.98%-659.19K
-435.46%-779.32K
-245.18%-365.35K
-69.19%-105.56K
-43.39%-38.89K
-105.78%-145.54K
Asset deal income
----
--345.96K
--352.14K
--352.14K
----
--0
----
----
----
--1.34M
Other revenue
-34.26%3.97M
141.51%21.16M
180.48%15.66M
210.14%9.46M
306.85%6.04M
-7.24%8.76M
-23.17%5.58M
-28.11%3.05M
-33.61%1.48M
49.45%9.45M
Operating profit
-59.68%142.45M
-43.30%956.99M
-40.69%767.94M
-37.43%575.43M
-16.51%353.33M
50.51%1.69B
66.69%1.29B
93.47%919.68M
98.48%423.23M
105.72%1.12B
Add:Non operating Income
3,905.58%177.95K
28.09%1.41M
-83.24%179.73K
151.86%169.66K
-90.21%4.44K
-44.30%1.1M
462.05%1.07M
-61.40%67.37K
35.31%45.4K
5,650.76%1.98M
Less:Non operating expense
17.64%3.92M
43.13%19.71M
-8.54%16.34M
52.00%16.1M
146.33%3.33M
142.99%13.77M
114.25%17.87M
83.51%10.59M
-53.11%1.35M
-90.15%5.67M
Total profit
-60.37%138.71M
-43.96%938.69M
-41.17%751.77M
-38.46%559.5M
-17.05%350M
49.87%1.68B
66.27%1.28B
93.54%909.16M
100.55%421.92M
129.21%1.12B
Less:Income tax cost
-53.58%28.69M
-38.00%170.34M
-30.25%140.87M
-26.54%104.93M
-10.82%61.8M
55.09%274.74M
57.24%201.97M
81.04%142.83M
98.33%69.29M
132.74%177.15M
Net profit
-61.83%110.02M
-45.13%768.35M
-43.22%610.9M
-40.68%454.58M
-18.27%288.21M
48.88%1.4B
68.08%1.08B
96.06%766.33M
100.99%352.63M
128.56%940.56M
Net profit from continuing operation
-61.83%110.02M
-45.13%768.35M
-43.22%610.9M
-40.68%454.58M
-18.27%288.21M
48.88%1.4B
68.08%1.08B
96.06%766.33M
100.99%352.63M
128.56%940.56M
Less:Minority Profit
-5,842.68%-709.33K
-2,640.24%-662.75K
-1,369.10%-489.21K
-1,301.22%-282.59K
-206.22%-11.94K
2,514.97%26.09K
20,523.50%38.55K
21,386,700.00%23.53K
936,558.33%11.24K
250.67%997.72
Net profit of parent company owners
-61.58%110.73M
-45.08%769.01M
-43.17%611.39M
-40.64%454.86M
-18.26%288.22M
48.88%1.4B
68.07%1.08B
96.05%766.3M
100.98%352.61M
128.56%940.56M
Earning per share
Basic earning per share
-61.54%0.05
-46.03%0.34
-43.75%0.27
-41.18%0.2
-18.75%0.13
50.00%0.63
65.52%0.48
88.89%0.34
100.00%0.16
100.00%0.42
Diluted earning per share
-61.54%0.05
-46.03%0.34
-43.75%0.27
-41.18%0.2
-18.75%0.13
50.00%0.63
65.52%0.48
88.89%0.34
100.00%0.16
100.00%0.42
Other composite income
391.85%289.92K
-99.34K
Other composite income of parent company owners
----
391.85%289.92K
----
----
----
---99.34K
----
----
----
----
Total composite income
-61.83%110.02M
-45.11%768.64M
-43.22%610.9M
-40.68%454.58M
-18.27%288.21M
48.87%1.4B
68.08%1.08B
96.06%766.33M
100.99%352.63M
128.56%940.56M
Total composite income of parent company owners
-61.58%110.73M
-45.06%769.3M
-43.17%611.39M
-40.64%454.86M
-18.26%288.22M
48.87%1.4B
68.07%1.08B
96.05%766.3M
100.98%352.61M
128.56%940.56M
Total composite income of minority owners
-5,842.68%-709.33K
-2,640.24%-662.75K
-1,369.10%-489.21K
-1,301.22%-282.59K
-206.22%-11.94K
2,514.97%26.09K
20,523.50%38.55K
21,386,700.00%23.53K
936,558.33%11.24K
250.67%997.72
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -15.61%1.09B-19.83%4.62B-22.90%3.44B-26.50%2.35B-14.85%1.3B19.38%5.76B24.43%4.46B32.20%3.2B19.96%1.52B26.24%4.82B
Operating revenue -15.61%1.09B-19.83%4.62B-22.90%3.44B-26.50%2.35B-14.85%1.3B19.38%5.76B24.43%4.46B32.20%3.2B19.96%1.52B26.24%4.82B
Other operating revenue ----7.73%389.55M-----7.26%167.18M----17.19%361.61M----10.06%180.27M----25.07%308.58M
Total operating cost 0.63%953.57M-10.16%3.65B-15.98%2.65B-22.57%1.75B-13.75%947.59M11.26%4.06B13.95%3.15B18.97%2.26B5.55%1.1B12.55%3.65B
Operating cost 2.94%836.67M-10.84%3.27B-19.27%2.31B-27.13%1.51B-18.64%812.76M10.99%3.66B13.97%2.86B19.43%2.07B6.54%998.93M14.87%3.3B
Operating tax surcharges -20.60%17.15M-15.68%67.21M-17.57%55.64M-14.64%39.64M9.54%21.6M19.59%79.7M24.66%67.5M24.55%46.43M0.15%19.72M21.31%66.65M
Operating expense 23.40%9.81M14.29%29.19M-2.18%19.14M16.59%13.52M106.68%7.95M13.16%25.54M33.78%19.57M31.13%11.6M-18.95%3.85M96.96%22.57M
Administration expense -5.51%54.36M-8.06%152.02M30.48%157.76M33.51%110.13M22.95%57.53M15.52%165.34M12.92%120.91M12.33%82.49M13.95%46.79M-0.66%143.13M
Financial expense 76.10%13.49M-37.02%30.46M-40.17%25.4M-42.84%15.84M-39.50%7.66M-20.51%48.36M-3.82%42.46M-4.63%27.71M-47.17%12.67M-50.55%60.83M
-Interest expense (Financial expense) -17.49%8.93M-45.37%33.82M-12.62%30.82M-16.24%21.41M-29.85%10.82M-29.47%61.91M-45.02%35.27M-46.24%25.56M-44.06%15.43M-38.33%87.78M
-Interest Income (Financial expense) 60.59%-674.2K36.90%-4.66M30.03%-3.9M22.74%-3.01M2.61%-1.71M54.38%-7.38M55.38%-5.58M53.53%-3.89M67.01%-1.76M-210.78%-16.18M
Research and development -44.91%22.09M31.85%102.49M89.80%83.64M135.00%67.63M140.34%40.09M40.67%77.73M12.82%44.07M22.10%28.78M21.11%16.68M56.18%55.26M
Credit Impairment Loss 116.30%309.76K-155.16%-3.69M-448.19%-8.11M-2,459.15%-6.1M-353.17%-1.9M202.82%6.69M1,182.16%2.33M326.69%258.72K493.65%750.54K54.41%-6.5M
Asset Impairment Loss -----40.85%-24.05M-173.62%-23.13M-173.62%-23.13M----59.97%-17.07M73.25%-8.45M73.25%-8.45M-----157.62%-42.65M
Other net revenue -61.73%1.52M-10.94%-11.97M-147.89%-17.49M-72.26%-20.13M394.39%3.98M79.68%-10.79M80.52%-7.06M69.91%-11.68M91.36%-1.35M-58.72%-53.11M
Fair value change income ---901.17K-4,808.63%-1.48M-135.13%-226.4K101.94%4.35K--0102.66%31.5K135.44%644.5K95.84%-224.6K76.75%-519.93K-1,938.52%-1.18M
Invest income -1,053.40%-1.86M53.70%-4.26M71.71%-2.03M88.87%-702.78K94.75%-160.91K32.14%-9.2M38.19%-7.16M15.38%-6.31M-325.42%-3.07M-52.22%-13.55M
-Including: Investment income associates -244.09%-2.27M-618.09%-5.6M-538.58%-2.33M-1,275.88%-1.45M-1,594.98%-659.19K-435.46%-779.32K-245.18%-365.35K-69.19%-105.56K-43.39%-38.89K-105.78%-145.54K
Asset deal income ------345.96K--352.14K--352.14K------0--------------1.34M
Other revenue -34.26%3.97M141.51%21.16M180.48%15.66M210.14%9.46M306.85%6.04M-7.24%8.76M-23.17%5.58M-28.11%3.05M-33.61%1.48M49.45%9.45M
Operating profit -59.68%142.45M-43.30%956.99M-40.69%767.94M-37.43%575.43M-16.51%353.33M50.51%1.69B66.69%1.29B93.47%919.68M98.48%423.23M105.72%1.12B
Add:Non operating Income 3,905.58%177.95K28.09%1.41M-83.24%179.73K151.86%169.66K-90.21%4.44K-44.30%1.1M462.05%1.07M-61.40%67.37K35.31%45.4K5,650.76%1.98M
Less:Non operating expense 17.64%3.92M43.13%19.71M-8.54%16.34M52.00%16.1M146.33%3.33M142.99%13.77M114.25%17.87M83.51%10.59M-53.11%1.35M-90.15%5.67M
Total profit -60.37%138.71M-43.96%938.69M-41.17%751.77M-38.46%559.5M-17.05%350M49.87%1.68B66.27%1.28B93.54%909.16M100.55%421.92M129.21%1.12B
Less:Income tax cost -53.58%28.69M-38.00%170.34M-30.25%140.87M-26.54%104.93M-10.82%61.8M55.09%274.74M57.24%201.97M81.04%142.83M98.33%69.29M132.74%177.15M
Net profit -61.83%110.02M-45.13%768.35M-43.22%610.9M-40.68%454.58M-18.27%288.21M48.88%1.4B68.08%1.08B96.06%766.33M100.99%352.63M128.56%940.56M
Net profit from continuing operation -61.83%110.02M-45.13%768.35M-43.22%610.9M-40.68%454.58M-18.27%288.21M48.88%1.4B68.08%1.08B96.06%766.33M100.99%352.63M128.56%940.56M
Less:Minority Profit -5,842.68%-709.33K-2,640.24%-662.75K-1,369.10%-489.21K-1,301.22%-282.59K-206.22%-11.94K2,514.97%26.09K20,523.50%38.55K21,386,700.00%23.53K936,558.33%11.24K250.67%997.72
Net profit of parent company owners -61.58%110.73M-45.08%769.01M-43.17%611.39M-40.64%454.86M-18.26%288.22M48.88%1.4B68.07%1.08B96.05%766.3M100.98%352.61M128.56%940.56M
Earning per share
Basic earning per share -61.54%0.05-46.03%0.34-43.75%0.27-41.18%0.2-18.75%0.1350.00%0.6365.52%0.4888.89%0.34100.00%0.16100.00%0.42
Diluted earning per share -61.54%0.05-46.03%0.34-43.75%0.27-41.18%0.2-18.75%0.1350.00%0.6365.52%0.4888.89%0.34100.00%0.16100.00%0.42
Other composite income 391.85%289.92K-99.34K
Other composite income of parent company owners ----391.85%289.92K---------------99.34K----------------
Total composite income -61.83%110.02M-45.11%768.64M-43.22%610.9M-40.68%454.58M-18.27%288.21M48.87%1.4B68.08%1.08B96.06%766.33M100.99%352.63M128.56%940.56M
Total composite income of parent company owners -61.58%110.73M-45.06%769.3M-43.17%611.39M-40.64%454.86M-18.26%288.22M48.87%1.4B68.07%1.08B96.05%766.3M100.98%352.61M128.56%940.56M
Total composite income of minority owners -5,842.68%-709.33K-2,640.24%-662.75K-1,369.10%-489.21K-1,301.22%-282.59K-206.22%-11.94K2,514.97%26.09K20,523.50%38.55K21,386,700.00%23.53K936,558.33%11.24K250.67%997.72
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 0.00%
Sample Name
Sample Code
 -6.41%
Sample Name
Sample Code
 -8.09%
4
PETROCHINA
00857
-9.10%
5
CNOOC
00883
-10.14%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.59%
Sample Name
Sample Code
 +18.95%
Sample Name
Sample Code
 +6.49%
4
Lotus Holdings
600186
+3.15%
5
China Greatwall Technology Group
000066
-0.17%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 29, Eastern Time, Trump held a two-hour meeting in the White House Situation Room but has not yet reached a final decision on negotia Show More
Options Sir on Macro | Big Week Ahead! US-Iran Deal May Materialize + PCE Data Looms—How to Navigate Markets Next?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -